Global private equity and venture capital news and research

Posts Tagged ‘CRISPR’

24 April 2014

Versant invests $25m in Series A for gene editing business CRISPR

Versant Ventures has led a $25m Series A financing round for biopharmaceutical business CRISPR Therapeutics, which is currently working on a breakthrough gene editing technology.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016